Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

By C. Witton, J. R. Reeves, J. Going, T. Cooke, J. Bartlett. Journal of Pathology, 2003

634 citations recorded by the source corpus.

Subfields: Immunology and Allergy, Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/c475a53bfc36e14e998986340127b4cd58bb55f1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Phatsapong Yingchoncharoen
2. D. Richardson
3. D. Kalinowski

Citations in the corpus

• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, background): “It was reported that EGFR was overexpressed in 15–20% of breast carcinomas (Witton et al., 2003; Abd El-Rehim et al., 2004), whereas human epidermal receptor-2 (HER-2) was found to be highly 728 Yingchoncharoen et al.”